Research and innovation news

A drug has shown potential to improve heart function in women diagnosed with preeclampsia during their pregnancy, research carried out at Saint Mary’s Hospital has found.

The first UK patient has been treated in new COVID-19 research trialling the impact of an experimental arthritis drug, otilimab, on severe lung disease related to COVID-19.

The third chapter of a nine-part webcomic, Planet DIVOC-91, featuring articles and art by young adults about COVID-19, was recently published.

Manchester University NHS Foundation Trust’s (MFT) ground-breaking qUEST research, part of the Manchester Lung Health Checks programme, has been named among the top-recruiting cancer studies in Englan

Manchester doctors have played a leading role in global coronavirus research, which has found the first drug shown to increase survival rates in people hospitalised with COVID-19.

Manchester’s world-class health innovation campus – a joint venture between Manchester University NHS Foundation Trust and Manchester Science Partnerships (MSP) – takes a step forward.

A research study evaluating the presence of COVID-19 antibodies in children and young people is taking place at ourTrust.

A Wythenshawe Hospital patient with COVID-19 is the first Manchester University NHS Foundation Trust recruit to a clinical trial investigating the drug Anakinra to treat COVID-19.